Translation and Validation of the French mPCOSQ (mPCOSQ-F).

Launched by CHU DE REIMS · Jun 3, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on a study called the mPCOSQ-F, which is a questionnaire designed to understand how polycystic ovary syndrome (PCOS) affects the quality of life for women. The researchers are working to translate this questionnaire from English to French and make sure it is reliable and valid for French-speaking women with PCOS. The aim is to help better assess how this condition impacts daily living and well-being.

To participate in this study, women aged 18 to 45 who are fluent in French and have been diagnosed with PCOS according to recent guidelines are eligible. Participants will fill out the mPCOSQ-F questionnaire and another general health-related quality of life questionnaire called the SF-36. After a week or two, they will complete the mPCOSQ-F again to help researchers see if the questionnaire is consistent and useful. It's important to note that women who are pregnant, breastfeeding, or have certain medical conditions won't be able to participate. This study is still in the planning stage and is not yet recruiting participants.

Gender

FEMALE

Eligibility criteria

• Inclusion criteria:
• • Women aged 18 to 45
• • Fluent in french
• • Having a diagnosis of PCOS according to the international recommendations published in 2023
• • Willing to participate in the study
• • Affiliated to the french social security system
• Exclusion criteria:
• • Diagnosis of adrenal hyperplasia, androgen-producing tumor, Cushing's syndrome, or thyroid disorder
• • Pregnancy or breast-feeding
• • Under legal protection